NewslettersPancreatic Cell NewsTargeting Leucine-Rich Repeat Serine/Threonine-Protein Kinase 2 Sensitizes Anti-PD-L1 Immunotherapy of Pancreatic Ductal AdenocarcinomaBy Laurisa Dohm - August 1, 20230159Proteomic analysis was performed to compare changes of Panc02 cell lines cultured with conditional medium and leucine rich repeat kinase 2 was identified as a differential gene.[Molecular Therapy]Full ArticleGraphical Abstract